Title: Central Serous Chorioretinopathy (CSC): Causes, Symptoms & Treatment

Description: Learn about Central Serous Chorioretinopathy (CSC), including its causes, risk factors, symptoms, OCT findings, diagnosis, treatment options, complications, and prevention.

Focus Keyword: Central Serous Chorioretinopathy

Secondary Keywords: CSC eye disease, central serous retinopathy, central serous chorioretinopathy causes, CSC symptoms, CSC OCT, CSC treatment, choroidal thickening, subretinal fluid

Introduction

Central Serous Chorioretinopathy (CSC) is a chorioretinal disorder in which fluid accumulates beneath the neurosensory retina, often affecting the macular region responsible for detailed central vision.

The condition is strongly associated with abnormalities of the choroid, including increased choroidal vascular permeability and, in many patients, a thickened choroid. Dysfunction of the retinal pigment epithelium (RPE) also plays an important role.

Patients with CSC may notice:

• Blurred central vision
• Distorted vision
• A dark or gray spot in central vision
• Objects appearing smaller than they really are
• Reduced contrast sensitivity
• Changes in color perception

CSC is often self-limiting, particularly when it is an acute first episode. However, chronic or recurrent CSC can cause persistent retinal and RPE changes and potentially permanent visual impairment.

What Is Central Serous Chorioretinopathy?

Central Serous Chorioretinopathy is a disorder characterized by serous detachment of the neurosensory retina, usually caused by leakage or dysfunction at the level of the RPE in association with choroidal abnormalities.

In simple terms:

Choroidal dysfunction

↓

Increased vascular permeability

↓

RPE dysfunction/leakage

↓

Fluid accumulates beneath the retina

↓

Neurosensory retinal detachment

↓

Central visual symptoms

The condition is also commonly referred to as central serous retinopathy, although "central serous chorioretinopathy" better reflects the important role of the choroid.

Why Is the Choroid Important in CSC?

The choroid is the vascular layer located between the retina and sclera.

It supplies the outer retina and RPE with:

• Oxygen
• Nutrients
• Blood flow
• Metabolic support

In CSC, abnormalities of the choroidal circulation are thought to contribute to increased vascular permeability and fluid accumulation.

Central Serous Chorioretinopathy: Who Is at Risk?

CSC can occur in people of different ages, but it is particularly recognized in young to middle-aged adults and has historically been reported more frequently in men.

Important risk factors include:

• Corticosteroid exposure
• Psychological stress
• Sleep disturbances
• Certain personality/stress-related factors
• Endogenous corticosteroid excess
• Pregnancy
• Some systemic conditions

Not every person with these factors develops CSC.

Corticosteroids and Central Serous Chorioretinopathy

One of the most clinically important associations is corticosteroid exposure.

CSC has been associated with corticosteroids administered through different routes, including:

• Oral corticosteroids
• Intravenous corticosteroids
• Inhaled corticosteroids
• Intranasal corticosteroids
• Topical corticosteroids
• Periocular corticosteroids
• Other steroid exposures

Importantly, patients should not stop prescribed corticosteroids suddenly without medical advice. If CSC occurs in someone using steroids, the treating clinician should determine whether the medication can safely be reduced, changed, or discontinued.

Causes of Central Serous Chorioretinopathy

The exact cause of CSC is not completely understood.

Current understanding points toward an interaction between:

• Choroidal vascular dysfunction
• Increased choroidal permeability
• RPE dysfunction
• Hormonal influences
• Cortisol-related mechanisms
• Genetic susceptibility
• Environmental and systemic factors

CSC is therefore better understood as a multifactorial chorioretinal disorder rather than a disease caused by one single factor.

Pathophysiology of CSC

Understanding the mechanism helps explain the clinical findings.

Step 1: Choroidal Vascular Abnormality

The choroidal vessels may become dilated and hyperpermeable.

Step 2: Increased Fluid Movement

Increased vascular permeability can promote movement of fluid toward the RPE and outer retinal tissues.

Step 3: RPE Dysfunction

The RPE normally acts as an important barrier and fluid-pumping system.

When RPE function is disturbed, fluid handling becomes abnormal.

Step 4: Subretinal Fluid Accumulation

Fluid collects between the neurosensory retina and RPE.

Step 5: Serous Retinal Detachment

The accumulated fluid elevates the neurosensory retina.

Step 6: Visual Symptoms

If the macula or fovea is involved, central vision becomes distorted or blurred.

Symptoms of Central Serous Chorioretinopathy

Symptoms vary depending on the location and amount of subretinal fluid.

1. Blurred Central Vision

The most common symptom is reduced clarity of central vision.

Patients may notice difficulty with:

• Reading
• Recognizing faces
• Driving
• Looking at fine details

2. Metamorphopsia

Straight lines may appear:

• Bent
• Wavy
• Distorted

This is particularly noticeable when looking at a grid or lined object.

3. Micropsia

Objects may appear smaller than they actually are.

4. Central Scotoma

Patients may perceive a gray, dark, or blurry area in the center of vision.

5. Reduced Contrast

Fine details may become less distinct, particularly under low-contrast conditions.

6. Color Vision Changes

Some patients report that colors appear less vivid or altered.

7. Hyperopic Shift

Some patients may experience a temporary refractive change toward hyperopia due to changes in the retinal contour.

Can CSC Affect One or Both Eyes?

CSC can affect:

• One eye
• Both eyes

Even when only one eye has obvious symptoms, the other eye may show subtle structural changes associated with the pachychoroid spectrum.

Therefore, clinicians commonly examine both eyes.

Acute vs Chronic Central Serous Chorioretinopathy

CSC can be broadly considered according to its clinical course.

Acute CSC

Acute CSC is generally characterized by a relatively recent onset of subretinal fluid.

Many acute cases resolve spontaneously over several weeks to a few months.

Chronic CSC

Chronic CSC involves persistent or recurrent subretinal fluid and/or longer-term RPE abnormalities.

Chronic disease can cause:

• RPE atrophy
• Photoreceptor damage
• Persistent visual dysfunction
• Reduced contrast sensitivity
• Permanent visual loss in some patients

Recurrent Central Serous Chorioretinopathy

Some patients experience repeated episodes.

Recurrent CSC may result in cumulative damage to:

• RPE
• Photoreceptors
• Outer retina

Repeated episodes should therefore be evaluated carefully, particularly when visual symptoms persist or recur.

Diagnosis of Central Serous Chorioretinopathy

Diagnosis is based on the combination of:

• Symptoms
• Clinical examination
• OCT
• Fundus findings
• Angiographic imaging when necessary

1. Dilated Fundus Examination

Fundus examination may reveal:

• Serous retinal elevation
• RPE abnormalities
• RPE pigmentary changes
• Areas of previous disease

2. Optical Coherence Tomography

OCT is one of the most important investigations for diagnosing and monitoring CSC.

Typical OCT findings may include:

• Subretinal fluid
• Serous elevation of the neurosensory retina
• RPE irregularities
• Pigment epithelial detachments
• Increased choroidal thickness in many patients
• Photoreceptor abnormalities in chronic disease

High-Yield OCT Finding

Subretinal fluid beneath the neurosensory retina is a classic OCT finding in active CSC.

3. Enhanced-Depth Imaging OCT

Enhanced-depth imaging OCT can improve visualization of the choroid.

It may demonstrate:

• Increased subfoveal choroidal thickness
• Dilated Haller's layer vessels
• Changes associated with pachychoroid

4. Fundus Autofluorescence

Fundus autofluorescence can help identify areas of RPE dysfunction.

It can be especially useful for assessing the extent of chronic or previous CSC-related changes.

5. Fluorescein Angiography

Fluorescein angiography can demonstrate characteristic leakage patterns.

A classic finding is the:

"Smoke-stack" pattern

A vertical column of dye leakage may be seen in some cases.

Another pattern is:

"Ink-blot" pattern

A localized expanding area of leakage is observed.

Exam Point

Ink-blot and smoke-stack patterns are classic fluorescein angiography descriptions of CSC.

6. Indocyanine Green Angiography

ICGA can provide information about deeper choroidal circulation.

It can demonstrate:

• Choroidal hyperpermeability
• Abnormal choroidal vascular patterns
• Dilated choroidal vessels

It may be particularly useful in chronic CSC and pachychoroid-spectrum disease.

7. OCT Angiography

OCT angiography can help identify abnormal vascular networks.

This can be particularly important when evaluating chronic CSC with suspected secondary choroidal neovascularization.

Central Serous Chorioretinopathy and Pachychoroid

CSC is closely associated with the pachychoroid spectrum.

Pachychoroid refers to a group of disorders characterized by characteristic structural and vascular changes in the choroid, often including increased choroidal thickness.

Features may include:

• Thickened choroid
• Dilated Haller's layer vessels
• Compression of smaller choroidal vessels
• Choroidal hyperpermeability
• RPE abnormalities

Central Serous Chorioretinopathy Treatment

Treatment depends on:

• Duration of disease
• Severity
• Recurrence
• Visual symptoms
• Presence of complications
• Whether the condition is acute or chronic

Not every patient with CSC requires immediate treatment.

1. Observation

Many acute CSC cases resolve spontaneously.

Observation may be appropriate when:

• The episode is recent
• Vision is reasonably preserved
• Symptoms are mild
• There are no significant complications

During observation, the patient may undergo repeat examination and OCT.

2. Photodynamic Therapy

Photodynamic therapy (PDT) is an important treatment for persistent or chronic CSC.

A photosensitizing agent is administered intravenously and activated using a specific wavelength of laser light.

PDT can reduce abnormal choroidal vascular hyperpermeability.

Reduced-Fluence or Reduced-Dose PDT

Modified PDT protocols are commonly used to reduce the risk of treatment-related complications while targeting abnormal choroidal circulation.

3. Focal Laser Photocoagulation

Laser treatment may be considered in selected patients when a clearly defined extrafoveal leakage point is present.

Because direct laser treatment near the fovea can damage central vision, it must be carefully planned.

4. Anti-VEGF Treatment

Anti-VEGF injections are not routine treatment for uncomplicated CSC.

However, anti-VEGF therapy may be considered when CSC is complicated by:

Choroidal neovascularization (CNV).

This distinction is clinically important.

CSC alone

→ Usually not primarily an anti-VEGF disease.

CSC + CNV

→ Anti-VEGF therapy may be indicated.

5. Corticosteroid Management

Because corticosteroids can contribute to CSC, clinicians may review whether steroid exposure can be reduced or modified.

Patients should never independently stop essential corticosteroid treatment.

Any change should be made in consultation with the prescribing clinician.

6. Mineralocorticoid Receptor Antagonists

Medications such as eplerenone have been investigated in CSC.

However, evidence has not established them as a universally effective standard treatment for CSC, and they are not routinely recommended for every patient.

Treatment decisions should therefore be based on current clinical evidence and specialist assessment.

Lifestyle and Supportive Measures

Lifestyle modification may be useful, particularly when addressing potential triggers.

Manage Stress

Because stress and cortisol-related mechanisms may be associated with CSC, stress management may be helpful.

Possible strategies include:

• Regular physical activity
• Adequate sleep
• Relaxation techniques
• Healthy work-rest balance

Improve Sleep

Maintaining a regular sleep schedule may support overall health.

Review Steroid Exposure

Tell your eye doctor about all corticosteroid medications you use.

This includes medications for:

• Asthma
• Allergies
• Skin disorders
• Joint disease
• Autoimmune conditions
• Other inflammatory conditions

Complications of Central Serous Chorioretinopathy

Acute CSC often has a favorable visual outcome, but chronic or recurrent disease can produce complications.

1. RPE Atrophy

Persistent disease can damage the RPE.

2. Photoreceptor Damage

Long-standing subretinal fluid can affect photoreceptor integrity.

3. Persistent Visual Dysfunction

Even after fluid resolves, some patients may continue to experience:

• Distortion
• Reduced contrast
• Color changes
• Reduced visual quality

4. Choroidal Neovascularization

CNV can develop, particularly in chronic disease and certain pachychoroid-spectrum presentations.

5. Permanent Visual Loss

Severe chronic or recurrent disease can result in lasting visual impairment.

Prognosis of Central Serous Chorioretinopathy

The prognosis depends on the clinical type.

Acute CSC

Many patients experience spontaneous resolution and improvement in vision.

Chronic CSC

Persistent disease has a greater risk of structural retinal damage and long-term visual dysfunction.

Recurrent CSC

Repeated episodes may increase the risk of cumulative RPE and photoreceptor damage.

Regular follow-up is therefore particularly important for chronic or recurrent disease.

Central Serous Chorioretinopathy vs Age-Related Macular Degeneration

CSC and neovascular AMD can both cause:

• Subretinal fluid
• Central visual distortion
• Reduced vision

However, they are different disorders.

CSC can produce serous elevation of the neurosensory retina, but this is different from a rhegmatogenous retinal detachment.

CSC

Usually:

Choroidal/RPE dysfunction → subretinal fluid

Rhegmatogenous retinal detachment

Usually:

Retinal break → fluid enters beneath retina → retinal separation

When Should You See an Eye Doctor?

Prompt ophthalmic evaluation is important if you develop:

• Sudden blurred central vision
• New distortion of straight lines
• A dark or gray central spot
• Sudden changes in color perception
• Unexplained reduction in visual acuity
• Persistent visual distortion
• Recurrent visual symptoms

Sudden visual loss should be treated as an urgent eye problem, because several retinal conditions can produce symptoms similar to CSC.

How Is CSC Monitored?

Monitoring commonly includes:

Visual Acuity

Measures central visual function.

OCT

Tracks:

• Subretinal fluid
• RPE changes
• Retinal thickness
• Choroidal thickness

Fundus Examination

Evaluates retinal and RPE changes.

OCTA

May be used when CNV is suspected.

The monitoring schedule depends on disease severity and clinical course.

Can Central Serous Chorioretinopathy Be Prevented?

There is no guaranteed way to prevent CSC.

However, patients can reduce potentially modifiable risk factors.

Practical measures include:

• Use corticosteroids only when medically necessary.
• Inform healthcare providers about previous CSC.
• Do not stop prescribed steroids without medical advice.
• Maintain healthy sleep habits.
• Manage chronic stress.
• Attend follow-up appointments.
• Seek evaluation for recurrent visual distortion.

Easy Mnemonic for CSC

CSC = Choroid → Serous Fluid → Central vision

C → Choroidal abnormality

S → Serous subretinal fluid

C → Central visual symptoms

Another simple memory aid:

CSC = STRESS + STEROID + SUBRETINAL FLUID

One-Minute Revision

Central Serous Chorioretinopathy

↓

Choroidal vascular dysfunction

↓

Increased choroidal permeability

↓

RPE dysfunction

↓

Subretinal fluid

↓

Neurosensory retinal detachment

↓

Blurred/distorted central vision

Diagnosis

OCT → subretinal fluid

FA → ink-blot/smoke-stack leakage patterns

ICGA → choroidal abnormalities

Treatment

Acute → observation in appropriate cases

Chronic/persistent → PDT is an important treatment

CNV → consider anti-VEGF

Conclusion

Central Serous Chorioretinopathy (CSC) is an important chorioretinal disorder characterized by subretinal fluid accumulation, usually involving the macular region. Abnormalities in the choroidal circulation and RPE function play central roles in its development.

The condition is strongly associated with corticosteroid exposure and may also be associated with stress, sleep disturbances, and other systemic factors. OCT is the key investigation for identifying and monitoring subretinal fluid, while fluorescein angiography and indocyanine green angiography can provide additional information in selected cases.

Many acute cases resolve spontaneously, but chronic and recurrent CSC require careful monitoring because persistent subretinal fluid can damage the RPE and photoreceptors. Photodynamic therapy is an important treatment option for chronic or persistent disease, while anti-VEGF therapy is generally reserved for cases complicated by choroidal neovascularization.

Recognizing symptoms such as new central distortion, blurred vision, or a central gray spot and obtaining appropriate ophthalmic evaluation can help ensure timely diagnosis and management.